MIR367: MIR367 is a microRNA that has been studied in various contexts. It has been found that the numbers of daily modRNA transfections required for reprogramming were reduced from 17 [PMC8348611]. In a study, four members of the miR302 cluster (miR302a, miR302b, miR302c, miR302d) were overexpressed, but not MIR367 [PMC4400607]. MIR367 is part of the miR302/367 cluster and is highly expressed in embryonic stem cells but declines rapidly after differentiation [PMC6722449]. It has been found that MIR367 functions as a tumor-promoting microRNA and its inhibition attenuates tumor aggressiveness and proliferation in embryonal tumors [PMC8235499]. MIR367 has also been used in reprogramming processes to induce somatic cells into induced pluripotent stem cells (iPSCs) without introducing exogenous transcription factors [PMC9026204]. In addition, serum MIR367 levels have been found to be aberrantly upregulated in esophageal squamous cell carcinoma (ESCC) patients and may serve as a circulating biomarker for ESCC [PMC6301302]. Furthermore, circulating exosomal miRNAs, including MIR367, have shown potential to discriminate individuals with esophageal adenocarcinoma from healthy controls and nondysplastic Barrett's esophagus [PMC5951134][PMC3466310][PMC8575592][PMC8575592][PMC8575592][PMCID8575592]. Overall, MIR367 plays various roles in different biological processes and diseases.